Altimmune Inc (ALT)
6.55
+0.16
(+2.42%)
USD |
NASDAQ |
Apr 30, 16:00
6.46
-0.09
(-1.37%)
After-Hours: 07:51
Altimmune Free Cash Flow: -75.86M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -75.86M |
| September 30, 2023 | -76.67M |
| June 30, 2023 | -71.29M |
| March 31, 2023 | -68.64M |
| December 31, 2022 | -62.71M |
| September 30, 2022 | -67.49M |
| June 30, 2022 | -70.27M |
| March 31, 2022 | -80.24M |
| December 31, 2021 | -90.55M |
| September 30, 2021 | -81.86M |
| June 30, 2021 | -73.55M |
| March 31, 2021 | -54.10M |
| December 31, 2020 | -34.65M |
| September 30, 2020 | -23.23M |
| June 30, 2020 | -16.08M |
| March 31, 2020 | -11.90M |
| December 31, 2019 | -9.631M |
| September 30, 2019 | -12.79M |
| June 30, 2019 | -11.54M |
| March 31, 2019 | -8.296M |
| December 31, 2018 | -10.40M |
| September 30, 2018 | -10.08M |
| June 30, 2018 | -13.17M |
| March 31, 2018 | -21.21M |
| December 31, 2017 | -20.38M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.08M |
| June 30, 2017 | -14.81M |
| March 31, 2017 | -8.618M |
| December 31, 2016 | -6.574M |
| September 30, 2016 | -6.887M |
| June 30, 2016 | -6.213M |
| March 31, 2016 | -1.909M |
| December 31, 2015 | -3.302M |
| September 30, 2015 | -4.978M |
| June 30, 2015 | -5.776M |
| March 31, 2015 | -8.984M |
| December 31, 2014 | -8.566M |
| September 30, 2014 | -11.30M |
| June 30, 2014 | -9.854M |
| March 31, 2014 | -9.819M |
| December 31, 2013 | -7.253M |
| September 30, 2013 | -3.141M |
| June 30, 2013 | -0.7161M |
| March 31, 2013 | -2.879M |
| December 31, 2012 | -2.323M |
| September 30, 2012 | -0.983M |
| June 30, 2012 | -6.377M |
| March 31, 2012 | -5.001M |
| December 31, 2011 | -7.88M |
| September 30, 2011 | -13.84M |
Free Cash Flow Range, Past 5 Years
-90.55M
Minimum
Dec 2021
-9.631M
Maximum
Dec 2019
-52.27M
Average
-67.49M
Median
Sep 2022
Free Cash Flow Benchmarks
| Eli Lilly and Co | -3.152B |
| Amgen Inc | 7.359B |
| Pfizer Inc | 4.793B |
| Viking Therapeutics Inc | -54.87M |
| Precision BioSciences Inc | -86.39M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.53M |
| Cash from Investing (Quarterly) | -7.959M |
| Cash from Financing (Quarterly) | 72.75M |
| Free Cash Flow Per Share (Quarterly) | -0.2826 |
| Free Cash Flow to Equity (Quarterly) | -16.53M |
| Free Cash Flow to Firm (Quarterly) | -16.53M |
| Free Cash Flow Yield | -21.75% |